CONNECTIVITY

INJECTION

HERE TODAY AND DEFINITELY NOT GONE TOMORROW: WHY SIMPLICITY AND EASE OF USE ARE THE KEY FOR A NEW GENERATION OF REUSABLE INJECTORS

Kate Hudson-Farmer discusses how a new electronic reusable autoinjector – the Aria Smart Autoinjector from Phillips-Medisize – has been designed and user-tested to challenge the preconceived ease-of-use notions about electronic autoinjectors, in addition to addressing how macro trends and personal consumer subtleties could become increasingly important in creating a competitive position as devices seek to improve patient engagement.

CONNECTIVITY

CONNECTED DEVICES CHALLENGE: HOW TO DEVELOP CONCEPT DEVICES WITH PEEK POLYMERS

Marcus Jarman-Smith, Adam Salmen, John Devine, Ernst Hupkes and Dennis Freie discuss the value of PEEK, a high-performance polymer, in drug delivery device design, using two concept devices – an on-body patch pump and vaporiser inhaler.

EXPERT VIEW

Enrico Denna

USING SIMULATION AND MODELLING VERSUS PROTOTYPING FOR MEDICAL RADIO FREQUENCY DESIGN

Enrico Denna looks at the advantages of a simulation and modelling approach over prototyping for the design of medical products.

WEARABLES

Wim Vos

Celanese

VECTRA^® MT^® LCP BRINGS THE ADVANTAGES OF LIQUID CRYSTAL POLYMERS TO WEARABLE INJECTORS

Wim Vos, Dave Pellegrino and Rob Haley discuss the myriad benefits of Vectra^® MT^® LCP, Celanese’s medical-grade liquid crystal polymer, for wearable injection devices, including improved patient comfort, greater design flexibility and reduced processing costs.

EXPERT VIEW

Tim Resker

OPTIONS FOR ACTIVATION OF BATTERY-OPERATED MEDICAL DEVICES

Tim Resker looks at new technologies for powering on battery-operated drug delivery devices while considering battery drain, ingress protection and user-friendliness.

INDUSTRIALISATION

Jens Schou Christensen

Stevanato Group

HOW DIGITISATION IS DELIVERING COMPETITIVE ADVANTAGE IN DEVICE ASSEMBLY

Jens Schou Christensen and Sebastian Berninger-Lund present the business case for the wider implementation of digitisation and the greater use of data to deliver assembly line improvements.

INDUSTRIALISATION

Napoleon Monroe

New Directions Technology Consulting

INDUSTRIALISATION OF DRUG DELIVERY BEYOND MANUFACTURING

Napoleon Monroe considers the impact of the changing technological landscape on how industrialisation in the healthcare industry is evolving, with reference to the idea of “patients as consumers” and how the relationship between consumers, information and industry has evolved in other sectors, such as tech and retail – and how big players in those sectors are looking to move into and disrupt healthcare.

GI/ORAL

Gary Pond

Colorcon

SMARTER MEDICINES TO SECURE PRODUCTS AND PROMOTE PATIENT ENGAGEMENT

Gary Pond looks at digital authentication and discusses how on-dose microtaggants can provide a high level of security in authenticating tablets and capsules in the fight against counterfeit products.

CONNECTIVITY

Arnaud Guillet

Biocorp

BIOCORP’S MALLYA – CHRONICLING A SUCCESS STORY

 Arnaud Guillet and colleagues from across the industry, discuss Bicorp’s Mallya add-on device for disposable insulin pens, providing details on the main country launches and key software integrations, as well as presenting initial feedback from healthcare professionals and patients.

CONNECTIVITY

Napoleon Monroe

New Directions Technology Consulting

PATENTS ARE IMPORTANT FOR SMART HEALTHCARE PRODUCTS

Napoleon Monroe discusses the value of internet-connected smart devices in present-day healthcare, and introduces the mMed patent portfolio, of which Mr Monroe is the sole inventor, and which contains five US patents for key connected health technologies.

EXPERT VIEW

Dr Ben Cox

THE POWER OF ONBOARDING: BUILDING PERSUASIVE USER EXPERIENCES FOR COMPANION APPS

Ben Cox discusses the value of onboarding in drug delivery device companion apps, and how it is a key component of converting a one-time user to a repeat user, unlocking the true value of companion apps as a tool for combating poor adherence to medications and gathering high-quality data.

CONNECTIVITY

Josh Hopkins

Noble

HOW DIGITAL MEDICAL DEVICES ARE MEETING THE CHALLENGES OF CLINICAL TRIALS

Josh Hopkins discusses the challenges that have been present in conducting clinical trials at a central brick-and-mortar location since their inception, and how modern digitisation presents an opportunity to improve clinical trial methodology by liberating it from the need for an in-person central study site via the use of digital medical devices and technologies.

CONNECTIVITY

Matthew Sarkar

Sagentia Innovation

IMPROVING PATIENT OUTCOMES WITH ADVANCED DIGITAL BIOMARKERS

Matthew Sarkar and Imantha Samaranayake consider the contribution digital biomarker devices make towards healthcare and the challenges faced by the evolution of such devices.

CONNECTIVITY

Christina Philpott

Recipe Design

MEANING-CENTRED PRODUCT DEVELOPMENT: THE KEY TO SUCCESSFUL CONNECTED DISEASE MANAGEMENT

Christina Philpott, Miles Hawley and Natasha French, discuss the future of connected disease management and the potential benefits for asthma treatment.

CONNECTIVITY

John Whitehouse

DCA

CYBERSECURITY AND CONNECTED DRUG DELIVERY – AN INTEGRATED RISK-BASED APPROACH

John Whitehouse, Rob Veasey and Shane Day, discuss the value of integrating cybersecurity into a holistic, multidisciplinary approach to risk management for connected medical devices.

CONNECTIVITY

Adam Shain

Aptar Pharma

PUTTING THEIR HEALTH IN THEIR HANDS: ENHANCING RESPIRATORY PATIENT OUTCOMES THROUGH DIGITAL THERAPEUTICS

Adam Shain discusses the role digital therapeutics play in respiratory patient outcomes and looks at the potential for expansion into other therapy areas.

CONNECTIVITY

Dr Young Kim

Celanese

SPECIALTY LCP COMPOUNDS FOR ELECTRONICS INTEGRATION IN CONNECTED MEDICAL DEVICES

Young Kim, Don DeMello and Philip Wilson, discuss the benefits of recent advances in liquid crystal polymer for connected medical devices.

CONNECTIVITY

Bjarne Sørensen

Phillips-Medisize

RE-USABLE ELECTRONIC AUTOINJECTOR – FLEXIBLE PERFORMANCE

Bjarne Sørensen discusses the ability of electronically driven injection devices to cater for a broad range of liquid drug properties within a single device platform.

INJECTION

Jimmy Fan

CC Bio

I-PLATFORM DEVICE: THE SMART DEVICE WITH APTITUDE

Jimmy Fan outlines the capabilities and benefits of the I-Platform smart drug delivery device.

CONNECTIVITY

Arnaud Guillet

Biocorp

INJAY: SIMPLE BY CHOICE, ADAPTABLE BY DESIGN

Arnaud Guillet discusses Biocorp’s Injay solution for adding connectivity to a wide variety of PFS devices, focusing on how Injay’s designed-in simplicity and flexibility makes it easily applicable across the spectrum of PFS platforms on the market today.

CONNECTIVITY

Mauro Citterio

Berry Global Healthcare

RS01X – BERRY GLOBAL HEALTHCARE’S SINGLE-DOSE DPI GOES DIGITAL WITH AMIKO’S RESPIRO

Mauro Citterio, Director, Marco Franza and Martijn Grinovero discuss Berry and Amiko’s partnership to develop the RS01X connected single-dose dry powder inhaler, based on Berry’s commercialised RS01 inhaler and Amiko’s Respiro digital health platform.

EXPERT VIEW

George I’ons

CONNECTED DRUG DELIVERY: ACHIEVING OPTIMAL BENEFITS THROUGH SMART COLLABORATION

George I’ons discusses the challenges developing connected devices presents to key market stakeholders when it comes to successful rollout and implementation. Additionally, he considers the perspectives of these market players, as well as the patients themselves, with respect to how connected drug delivery devices can help them to better achieve their desired outcomes.

CONNECTIVITY

Mr Michael Kiely

Jabil Healthcare

MEDICAL DEVICE DESIGN STRATEGY FOR A CONNECTED FUTURE

Michael Kiely, Laura Marsden, Peter Stringer, and David Boyle discuss the design challenges at the electromechanical interface and encourage manufacturers to adopt a standardised approach for connecting medical devices to the cloud.

CONNECTIVITY

Neil Williams

Phillips-Medisize

THE CHANGING FACE OF CONNECTED HEALTH IN THE TIME OF COVID-19

Neil Williams and Angela R Eder both of Phillips-Medisize, discuss how the current pandemic is transforming the adoption of connected health.

CONNECTIVITY

Arnaud Guillet

Biocorp

MALLYA: ENLIGHTENING PAST, EXCITING PRESENT, PROMISING FUTURE

Arnaud Guillet reviews the Mallya connected device platform, from the origins of the project to the current success in diabetes and deployment in other fields, and introduces the promising next-generation Mallya.

CONNECTIVITY

Marcus Bates

Aptar Pharma

THE COVID-19 CATALYST: HOW A GLOBAL PANDEMIC IS ACCELERATING THE NEED FOR DIGITAL HEALTH

Marcus Bates discusses the positive impact covid-19 has had on the digital health industry, including the acceleration and development of remote patient services.

CONNECTIVITY

Edgar Hernan Cuevas Brun

HCmed Innovations

IMPROVING INHALATION THERAPY ADHERENCE WITH CONNECTED DEVICES

 Edgar Hernan Cuevas Brun discusses the role of connectivity in improving adherence to medication and introduces the company’s mesh nebuliser smart cap, Pulmogine+.

CONNECTIVITY

Dr Fred Metzmann

Haselmeier

D-FLEX^® ECOSYSTEM – FROM DATA TO VALUE

Fred Metzmann and Frank Leipold discuss the benefits of connected medical devices in clinical trials and describe the advantages of Haselmeier's D-Flex^® Ecosystem for improving adherence and reducing the dropout rate in clinical trials.

PULMONARY

Edgar Hernan Cuevas Brun

HCmed Innovations

AN INTRODUCTION TO SMART BREATH-ACTUATED NEBULISERS

Edgar Hernan Cuevas Brun considers the benefits of smart breath-actuated nebulisers and looks at the latest technology contributing to the evolution of nebulisers.

INJECTION

Dr Iain Simpson

Phillips-Medisize

THE NEW EMERGING NEEDS DRIVING AUTOINJECTOR DEVELOPMENT

Iain Simpson discusses the emerging needs to be considered when bringing new autoinjector drug-device combinations to market.

CONNECTIVITY

Arnaud Guillet

Biocorp

MEASURING & MANAGING MEDICATION ADHERENCE FROM CLINICAL TRIALS TO ROUTINE CARE: INJAY MEMS AS^®

Arnaud Guillet and Bernard Vrijens discuss the issue of medication non-adherence in both clinical trials and commercialised drug products, and how Biocorp’s Injay connected prefilled syringe solution combined with Aardex’s MEMS Adherence Software provides a solution.

CONNECTIVITY

Sheila Trgovac

Ximedica

HOW DIGITAL TECHNOLOGY CAN TRANSFORM CLINICAL TRIALS

Sheila Trgovac and Rebecca Ford suggest that now is the time for innovation in clinical trials – using a patient-centric approach whilst leveraging digital solutions to create a digital clinical trial ecosystem.

WEARABLES

Tony Bedford

Phillips-Medisize

EMERGING TRENDS IN WEARABLE DRUG DELIVERY

Tony Bedford discusses the current state of the fledgling on-body injector market, including the difficulties of competing with autoinjectors in the <5 mL space, the potential on-body injectors have in oncology and Phillips-Medisize’s own developments in the on-body injector field.

EXPERT VIEW

Napoleon Monroe

COVID-19: A CATALYST FOR IMPLEMENTING CONNECTED HEALTHCARE PRODUCTS?

Napoleon Monroe analyses how covid-19 is catalysing a wide range of reactions in healthcare, explaining how drug and device connectivity are essential to improving patient access to treatment – and patient outcomes – as well as reducing overall cost. 

CONNECTIVITY

John Merhige

Credence MedSystems

THE AWARD-WINNING CREDENCE CONNECT™ AUTO-SENSING INJECTION SYSTEM

John Merhige explains how connectivity that is universally applicable to any existing prefilled syringe platform adds value throughout the ecosystem, both including and beyond the “compliance business model”.

CONNECTIVITY

Marnik Vaes

SABIC

POLYMERIC EMI SHIELDING: PROVIDING A MORE SECURE FUTURE FOR PATIENTS

Marnik Vaes, Leen-Pieter Deurloo and Martin Sas discuss the role of polymeric electromagnetic interference shielding in providing a more secure future for patients in a connected world.

CONNECTIVITY

Gaël Senée

Biocorp

SENSORS ARE TOOLS – BUT HOW DO YOU MAKE THEM SMART?

Gaël Senée and Arnaud Guillet explore the benefits of Mallya – a smart sensor that turns conventional injection pens into connected devices. They also discuss the crucial role Biocorp’s connected prefilled syringe, Injay, could play in future COVID-19 vaccination programmes.

EXPERT VIEW

Tom Oakley

RISKS AND REAL-WORLD SOLUTIONS FOR CONNECTED MEDICAL DEVICES

Tom Oakley discusses the risks surrounding the use of connected drug delivery devices – and the real-world solutions that have either been proved or are being trialled.